KPIs & Operating Metrics(New)
Breakdown Of AssetsEmployee StatisticsGross Margin %Gross ProfitIncome Before Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Number Of Billable Tests DeliveredOpex As A % Of RevenueOPEX BreakdownOther Current Assets BreakdownProperty And Equipment BreakdownRevenue By PayorRevenue By Payor %Revenue By Payor AnnualRevenue By Payor Annual %Revenue By RegionRevenue By Region %Revenue By Region AnnualRevenue By Region Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Fulgent Genetics (FLGT) Gross Profit (2016 - 2025)

Fulgent Genetics' Gross Profit history spans 12 years, with the latest figure at $21.5 million for Q1 2026.

  • On a quarterly basis, Gross Profit fell 24.19% to $21.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $124.0 million, a 9.31% increase, with the full-year FY2025 number at $130.9 million, up 22.07% from a year prior.
  • Gross Profit hit $21.5 million in Q1 2026 for Fulgent Genetics, down from $32.6 million in the prior quarter.
  • Over the last five years, Gross Profit for FLGT hit a ceiling of $242.5 million in Q1 2022 and a floor of $13.0 million in Q4 2022.
  • Historically, Gross Profit has averaged $43.0 million across 5 years, with a median of $28.3 million in 2025.
  • Biggest five-year swings in Gross Profit: crashed 93.15% in 2022 and later skyrocketed 94.26% in 2023.
  • Tracing FLGT's Gross Profit over 5 years: stood at $13.0 million in 2022, then skyrocketed by 94.26% to $25.2 million in 2023, then increased by 26.24% to $31.8 million in 2024, then grew by 2.3% to $32.6 million in 2025, then plummeted by 34.04% to $21.5 million in 2026.
  • Business Quant data shows Gross Profit for FLGT at $21.5 million in Q1 2026, $32.6 million in Q4 2025, and $35.5 million in Q3 2025.